For the clinical industry, the transition from atomic absorption spectroscopy (AAS) to inductively coupled plasma-mass spectrometry (ICP-MS) has been gradual over the past two decades
The agreement will drive medical innovation by making human biospecimens and associated data from within the GLHC network available to research program